IPO-38 Is Identified as a Novel Serum Biomarker of Gastric Cancer Based on Clinical Proteomics Technology
- 5 August 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 7 (9), 3668-3677
- https://doi.org/10.1021/pr700638k
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Quantitative Proteomic Analysis of Post-translational Modifications of Human HistonesMolecular & Cellular Proteomics, 2006
- Cancer Serum Proteomics in GastroenterologyGastroenterology, 2006
- Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modificationsGenes & Development, 2006
- The Inconsistency of “Optimal” Cutpoints Obtained using Two Criteria based on the Receiver Operating Characteristic CurveAmerican Journal of Epidemiology, 2006
- Proteomics of breast carcinomaJournal of Chromatography B, 2005
- Adjusting the generalized ROC curve for covariatesStatistics in Medicine, 2004
- Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkersProteomics, 2003
- Translating the Histone CodeScience, 2001
- The language of covalent histone modificationsNature, 2000
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998